10-26219128-A-C
Variant summary
Our verdict is Benign. The variant received -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_001134366.2(GAD2):c.372A>C(p.Lys124Asn) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000614 in 1,613,522 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001134366.2 missense
Scores
Clinical Significance
Conservation
Publications
Genome browser will be placed here
ACMG classification
Our verdict: Benign. The variant received -8 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000375 AC: 57AN: 152162Hom.: 1 Cov.: 33 show subpopulations
GnomAD2 exomes AF: 0.0000877 AC: 22AN: 250948 AF XY: 0.0000737 show subpopulations
GnomAD4 exome AF: 0.0000287 AC: 42AN: 1461242Hom.: 0 Cov.: 31 AF XY: 0.0000234 AC XY: 17AN XY: 726854 show subpopulations
GnomAD4 genome AF: 0.000374 AC: 57AN: 152280Hom.: 1 Cov.: 33 AF XY: 0.000389 AC XY: 29AN XY: 74462 show subpopulations
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.372A>C (p.K124N) alteration is located in exon 4 (coding exon 4) of the GAD2 gene. This alteration results from a A to C substitution at nucleotide position 372, causing the lysine (K) at amino acid position 124 to be replaced by an asparagine (N). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at